Market Bizzz

​These stocks’ 50-day simple moving averages (SMA) crossed their 200-day SMAs on June 24.

Companies like Tata Elxsi, Titan, and JSW Holdings are set to be in the spotlight this week with corporate actions such as dividends, stock splits, and annual general meetings lined up.

Eight stocks are under F&O trade ban, including Balrampur Chini Mills, GNFC, Hindustan Aeronautics, Hindustan Copper, Indus Towers, and Piramal Enterprises. Birlasoft exits ban list while Chambal Fertilisers and Granules enter. Ban lifted when open interest falls below 80%.

20 companies, including Nifty companies Titan and IndusInd Bank, have set record dates this week to determine dividend payouts. Shareholders buying stock at least one day before the ex-date are eligible for dividends under the T+1 framework, where ex-date and record date align in most cases.

D-Street showed marginal gains in a shortened trading week. However, signs of fatigue and potential correction are emerging. Key resistance levels are identified, and experts recommend caution and profit booking at higher levels.

Ashi Anand, Founder and CEO of IME Capital, provides an in-depth analysis of the Indian IT and auto sectors. Anand highlighted the persistent strength in deal wins across IT companies despite weaker-than-expected revenue growth, attributing this to reduced discretionary spending.

FIIs covering short positions in the Indian market may drive a potential rally, supported by DIIs and SIP. Amidst profit booking in FMCG stocks, focusing on rural demand and monsoon impact could offer buying opportunities. Private banks and financial companies show promising trends, while Nifty Auto and telecom sectors present favorable trading prospects.

Traders noted that there were no fundamental reasons for the two-day selloff. However, it highlights the rapid pace at which the stock had risen—nearly 200% in the past year—which now makes it susceptible to sudden declines like this one.

According to bulk deal data from BSE, Olympus Capital Asia Investments sold 4.50 crore shares, equivalent to a 9% stake in Aster DM Healthcare, in two tranches. The shares were sold within the price range of Rs 340 to Rs 340.13 each, totalling Rs 1,530.08 crore.

The market regulator conducted a suo-moto investigation to determine if the Chandra brothers routed funds to the Indian securities market through their UBS AG bank accounts, potentially violating the Prohibition of Fraudulent and Unfair Trade Practices (PFUTP) regulations.